The Plant-Based Vaccines Global Market Report 2023, provides comprehensive information on the plant-based vaccines market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Plant-Based Vaccines Market’s Growth:
https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report
In the dynamic landscape of global healthcare, the plant-based vaccines market is poised for substantial growth, projecting an impressive rise from $1.38 billion in 2022 to an estimated $1.52 billion in 2023, with a robust compound annual growth rate (CAGR) of 10.5%. However, the global economic recovery from the lingering effects of the COVID-19 pandemic faces unprecedented challenges, primarily catalyzed by the Russia-Ukraine war. The geopolitical turmoil has reverberated across nations, instigating economic sanctions, soaring commodity prices, and intricate supply chain disruptions. This ripple effect has triggered inflation across diverse sectors, impacting markets worldwide. Undeterred by these challenges, the plant-based vaccines market is anticipated to burgeon further, reaching an anticipated value of $2.24 billion in 2027, maintaining a commendable CAGR of 10.1%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12144&type=smp
In the dynamic landscape of the plant-based vaccine market, a pivotal trend is the surge in product innovation, heralding a new era of advancements. Leading entities within this sphere are strategically channeling their efforts into pioneering solutions to fortify their market standing. A notable illustration of this progressive momentum unfolded in February 2022 when Medicago Inc., a distinguished biopharmaceutical company based in Canada, collaboratively with GSK PLC, a prominent UK-based pharmaceutical and biotechnology powerhouse, announced the approval of COVIFENZ by Health Canada. Noteworthy for being the maiden plant-based virus-like particles (VLP), recombinant, adjuvanted vaccine for COVID-19, COVIFENZ harnesses cutting-edge coronavirus-like particle (CoVLP) technology. At its core, the vaccine integrates recombinant spike (S) glycoproteins fashioned into virus-like particles (VLPs), signifying a groundbreaking stride in the fight against coronavirus disease.
The plant-based vaccines market is segmented:
1) Plant-Based Vaccines Market By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types
2) Plant-Based Vaccines Market By Source: Tobacco Plant, Maize, Potato, Other Sources
3) Plant-Based Vaccines Market By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications
North America was the largest region in the plant-based vaccines market in 2022.
The table of contents in TBRC’s plant-based vaccines market report includes:
1. Executive Summary
2. Plant-Based Vaccines Market Characteristics
3. Plant-Based Vaccines Market Trends And Strategies
4. Plant-Based Vaccines Market - Macro Economic Scenario
......
32. Global Plant-Based Vaccines Market Competitive Benchmarking
33. Global Plant-Based Vaccines Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Plant-Based Vaccines Market
35. Plant-Based Vaccines Market Future Outlook and Potential Analysis
36. Appendix
Read Related Reports:
https://www.thebusinessresearchcompany.com/report/automotive-halogen-bulbs-global-market-report
https://www.thebusinessresearchcompany.com/report/automobile-rental-and-leasing-market
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
